Art. 4 Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 20…

Prior authorisation

In forcesince 16 Apr 2014cited 2×

A clinical trial shall be subject to scientific and ethical review and shall be authorised in accordance with this Regulation.

The ethical review shall be performed by an ethics committee in accordance with the law of the Member State concerned. The review by the ethics committee may encompass aspects addressed in Part I of the assessment report for the authorisation of a clinical trial as referred to in Article 6 and in Part II of that assessment report as referred to in Article 7 as appropriate for each Member State concerned.

Member States shall ensure that the timelines and procedures for the review by the ethics committees are compatible with the timelines and procedures set out in this Regulation for the assessment of the application for authorisation of a clinical trial.

  • Opinion of Advocate General Szpunar delivered on 9 January 2019. Viridis Pharmaceutical Ltd v European Union Intellectual Property Office.Decision

    Moreover, a clinical trial must in principle undergo a scientific and ethical examination and must be authorised before it starts. [See Article 9 of Directive 2001/20 and Article 4 of Regulation No 536/2014.] Also, any substantial …

    9 Jan 2019 · 62017CC0668

  • Order of the President of the General Court of 12 December 2025. Merck Europe BV v European Commission.Decision

    In circumstances such as those of the present case, under Article 5 of Regulation No 536/2014, applications for clinical trials are to be submitted to the competent authorities of the Member States. In addition, under the first paragraph …

    12 Dec 2025 · 62025TO0637